person · Reporting owner

FOSS ERIC J

Disclosed activity across 7 companies

Tapewire entity: 24236
SEC CIK: 0001197007

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
AramarkARMK · Entity 3359	Director · Chairman, President and CEO	May 30, 2019	June 03, 2019
Cigna GroupCI · Entity 550	Director	April 22, 2026	April 24, 2026
O-I Glass, Inc. /DE/OI · Entity 4907	Director	May 15, 2025	May 19, 2025
Primo Brands CorpPRMB · Entity 3622	Director · Exec. Chair and CEO	August 10, 2026	August 12, 2026
Primo Water Corp /CN/PRMW · Entity 86195	Director	November 08, 2024	November 12, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Aramark

Report date May 30, 2019 · Filed June 03, 2019

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,680,411.584	Reported balance After 2019-05-30 transaction · row 1 1 source row Row 1 · 2019-05-30 · Grant · Acquired 468.041 · Balance 1,680,411.584 F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Filing footnotes · ownership attribution and instrument terms

F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Cigna Group

Report date April 22, 2026 · Filed April 24, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, $.01 Par ValueSEC Table I · non-derivative	Direct	36,696	Reported balance After 2026-04-22 transaction · row 1 1 source row Row 1 · 2026-04-22 · Grant · Acquired 782 · Balance 36,696

O-I Glass, Inc. /DE/

Report date May 15, 2025 · Filed May 19, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock (Direct)SEC Table I · non-derivative	Direct	22,646	Reported balance After 2025-05-15 transaction · row 1 1 source row Row 1 · 2025-05-15 · Grant · Acquired 11,713 · Balance 22,646 F1: The restricted stock units vest in full on the date of the Company's next Annual Meeting of share owners at which directors are elected following the date of grant.

Filing footnotes · ownership attribution and instrument terms

F1: The restricted stock units vest in full on the date of the Company's next Annual Meeting of share owners at which directors are elected following the date of grant.

Primo Brands Corp

Report date August 10, 2026 · Filed August 12, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	573,806	Ending reported balance After 2026-08-10 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-08-10 · Purchase · Acquired 83,900 · Balance 573,706 F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $23.30 to $24.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Row 2 · 2026-08-10 · Purchase · Acquired 100 · Balance 573,806

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $23.30 to $24.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Primo Water Corp /CN/

Report date November 08, 2024 · Filed November 12, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common SharesSEC Table I · non-derivative	Direct	0	Reported balance After 2024-11-08 transaction · row 1 1 source row Row 1 · 2024-11-08 · Disposition to issuer · Disposed 18,445 · Balance 0 F1: Pursuant to that certain Arrangement Agreement and Plan of Merger, dated June 16, 2024, (as amended, the "Arrangement Agreement"), by and among the Issuer, Triton Water Parent, Inc. ("BlueTriton"), Triton US HoldCo, Inc., a wholly-owned subsidiary of BlueTriton ("Primo Brands Corporation" formerly referred to as "NewCo"), Triton Merger Sub 1, Inc., a wholly-owned subsidiary of Primo Brands Corporation and 1000922661 Ontario Inc., a wholly-owned subsidiary of Primo Brands Corporation, the reported securities were disposed of in exchange for shares of Primo Brands Corporation Class A common stock at an exchange ratio of 1:1.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to that certain Arrangement Agreement and Plan of Merger, dated June 16, 2024, (as amended, the "Arrangement Agreement"), by and among the Issuer, Triton Water Parent, Inc. ("BlueTriton"), Triton US HoldCo, Inc., a wholly-owned subsidiary of BlueTriton ("Primo Brands Corporation" formerly referred to as "NewCo"), Triton Merger Sub 1, Inc., a wholly-owned subsidiary of Primo Brands Corporation and 1000922661 Ontario Inc., a wholly-owned subsidiary of Primo Brands Corporation, the reported securities were disposed of in exchange for shares of Primo Brands Corporation Class A common stock at an exchange ratio of 1:1.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Cigna Holding Co

Report date December 20, 2018 · Filed December 26, 2018

Section 16 reporting ended · disclosed 2018-12-26. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, $.25 Par ValueSEC Table I · non-derivative	Direct	0	Reported balance After 2018-12-20 transaction · row 1 1 source row Row 1 · 2018-12-20 · Disposition to issuer · Disposed 14,346 · Balance 0 F1: Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote) F2: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote)

F2: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30.

Diversey Holdings, Ltd.

Report date July 05, 2023 · Filed July 06, 2023

Section 16 reporting ended · disclosed 2023-07-06. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary Shares, $0.0001 par valueSEC Table I · non-derivative	IndirectEric J. Foss Revocable Trust Agreement	0	Reported balance After 2023-07-05 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2023-07-05 · Disposition to issuer · Disposed 121,210 · Balance 0 F1: Pursuant to and in connection with the transactions contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 8, 2023, by and among the Issuer, Olympus Water Holdings IV, L.P. ("Parent"), acting by its general partner, Olympus Water Holdings Limited and Diamond Merger Limited, each of the Issuer's ordinary shares, par value $0.0001 per share (each, an "Ordinary Share"), owned by the Reporting Person were cancelled and exchanged into the right to receive $8.40 in cash (the "Merger Consideration"). F2: The number of shares reported were indirectly held within the Eric J. Foss Revocable Trust Agreement u/a/d 10/4/07 of which the Reporting Person is trustee.
Ordinary Shares, $0.0001 par valueSEC Table I · non-derivative	Direct	0	Reported balance After 2023-07-05 transaction · row 2 1 source row Row 2 · 2023-07-05 · Disposition to issuer · Disposed 634,350 · Balance 0 F1: Pursuant to and in connection with the transactions contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 8, 2023, by and among the Issuer, Olympus Water Holdings IV, L.P. ("Parent"), acting by its general partner, Olympus Water Holdings Limited and Diamond Merger Limited, each of the Issuer's ordinary shares, par value $0.0001 per share (each, an "Ordinary Share"), owned by the Reporting Person were cancelled and exchanged into the right to receive $8.40 in cash (the "Merger Consideration"). F3: The Ordinary Shares reported as disposed by the Reporting Person include 2,601 shares underlying restricted share units which, pursuant to the Merger Agreement, were vested and cancelled into the right to receive an amount in cash equal to the Merger Consideration, with payment subject to continued service with Parent and its affiliates, as applicable.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to and in connection with the transactions contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 8, 2023, by and among the Issuer, Olympus Water Holdings IV, L.P. ("Parent"), acting by its general partner, Olympus Water Holdings Limited and Diamond Merger Limited, each of the Issuer's ordinary shares, par value $0.0001 per share (each, an "Ordinary Share"), owned by the Reporting Person were cancelled and exchanged into the right to receive $8.40 in cash (the "Merger Consideration").

F2: The number of shares reported were indirectly held within the Eric J. Foss Revocable Trust Agreement u/a/d 10/4/07 of which the Reporting Person is trustee.

F3: The Ordinary Shares reported as disposed by the Reporting Person include 2,601 shares underlying restricted share units which, pursuant to the Merger Agreement, were vested and cancelled into the right to receive an amount in cash equal to the Merger Consideration, with payment subject to continued service with Parent and its affiliates, as applicable.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 10, 2026 Filed Aug 12, 2026 20:30 UTC	Primo Brands Corp PRMB · Entity 3622	PurchaseClass A Common Stock	100	$24.30	$2,430.00	Disclosure SEC source: 0001493152-26-037375 · ownership.xml · nonDerivative · entry 2 FOSS ERIC J · CIK 0001197007 · Director · Exec. Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 573,806 Read SEC document
August 10, 2026 Filed Aug 12, 2026 20:30 UTC	Primo Brands Corp PRMB · Entity 3622	PurchaseClass A Common Stock	83,900	$23.80	$1,996,543.13	Disclosure SEC source: 0001493152-26-037375 · ownership.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Exec. Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 573,706 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $23.30 to $24.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document
April 22, 2026 Filed Apr 24, 2026 20:59 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	782	$0.00	$0.00	Disclosure SEC source: 0001739940-26-000037 · wk-form4_1777064356.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,696 Read SEC document
December 10, 2025 Filed Dec 12, 2025 22:19 UTC	Primo Brands Corp PRMB · Entity 3622	GrantClass A Common Stock	129,770	$0.00	$0.00	Disclosure SEC source: 0001493152-25-027569 · ownership.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Exec. Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 489,806 F1 · kind: Represents an award of restricted stock units ("RSUs"), each of which represent a contingent right to receive one share of the Issuer's Class A Common Stock. The RSUs will vest in equal one-third installments on each of the first, second and third anniversaries of the grant date. Read SEC document
November 12, 2025 Filed Nov 13, 2025 13:00 UTC	Primo Brands Corp PRMB · Entity 3622	PurchaseClass A Common Stock	4,970	$16.15	$80,265.50	Disclosure SEC source: 0001493152-25-022121 · ownership.xml · nonDerivative · entry 2 FOSS ERIC J · CIK 0001197007 · Director · Exec. Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 360,036 F1 · shares: All shares were purchased in accordance with the daily volume and other limitations and requirements of Rule 10b-18. F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $16.02 to $16.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document
November 11, 2025 Filed Nov 13, 2025 13:00 UTC	Primo Brands Corp PRMB · Entity 3622	PurchaseClass A Common Stock	123,049	$15.52	$1,910,323.42	Disclosure SEC source: 0001493152-25-022121 · ownership.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Exec. Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 355,066 F1 · shares: All shares were purchased in accordance with the daily volume and other limitations and requirements of Rule 10b-18. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $15.35 to $15.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document
November 07, 2025 Filed Nov 11, 2025 00:30 UTC	Primo Brands Corp PRMB · Entity 3622	GrantClass A Common Stock	207,468	$0.00	$0.00	Disclosure SEC source: 0001493152-25-021588 · ownership.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Exec. Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,017 F1 · shares: Represents an award of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's Class A Common Stock. The RSUs will vest in equal one-third installments on each of the first, second and third anniversaries of the grant date. Read SEC document
May 15, 2025 Filed May 19, 2025 20:23 UTC	O-I Glass, Inc. /DE/ OI · Entity 4907	GrantCommon Stock (Direct)	11,713	$0.00	$0.00	Disclosure SEC source: 0001225208-25-005280 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,646 F1 · shares: The restricted stock units vest in full on the date of the Company's next Annual Meeting of share owners at which directors are elected following the date of grant. Read SEC document
May 01, 2025 Filed May 2, 2025 20:15 UTC	Primo Brands Corp PRMB · Entity 3622	GrantClass A Common Stock	5,317	$0.00	$0.00	Disclosure SEC source: 0000950170-25-062796 · ownership.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,549 F1 · shares: Class A Common Stock was granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy. The Reporting Person has deferred receiving the Class A Common Stock. Read SEC document
April 23, 2025 Filed Apr 25, 2025 20:32 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	638	$0.00	$0.00	Disclosure SEC source: 0001225208-25-004421 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,914 Read SEC document
November 08, 2024 Filed Nov 12, 2024 17:43 UTC	Primo Water Corp /CN/ PRMW · Entity 86195	Disposition to issuerCommon Shares	18,445	Not disclosed	Not disclosed	Disclosure SEC source: 0000884713-24-000118 · wk-form4_1731451392.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to that certain Arrangement Agreement and Plan of Merger, dated June 16, 2024, (as amended, the "Arrangement Agreement"), by and among the Issuer, Triton Water Parent, Inc. ("BlueTriton"), Triton US HoldCo, Inc., a wholly-owned subsidiary of BlueTriton ("Primo Brands Corporation" formerly referred to as "NewCo"), Triton Merger Sub 1, Inc., a wholly-owned subsidiary of Primo Brands Corporation and 1000922661 Ontario Inc., a wholly-owned subsidiary of Primo Brands Corporation, the reported securities were disposed of in exchange for shares of Primo Brands Corporation Class A common stock at an exchange ratio of 1:1. Read SEC document
November 08, 2024 Filed Nov 14, 2024 02:33 UTC	Primo Brands Corp PRMB · Entity 3622	GrantClass A Common Stock	787	$24.21	$19,053.27	Disclosure SEC source: 0001140361-24-046605 · form4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,232 Read SEC document
May 16, 2024 Filed May 17, 2024 20:15 UTC	O-I Glass, Inc. /DE/ OI · Entity 4907	GrantCommon Stock (Direct)	10,933	$0.00	$0.00	Disclosure SEC source: 0001225208-24-006189 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,933 F1 · shares: The restricted stock units vest in full on the date of the Company's next Annual Meeting of share owners at which directors are elected following the date of grant. Read SEC document
May 08, 2024 Filed May 10, 2024 16:19 UTC	Primo Water Corp /CN/ PRMW · Entity 86195	GrantCommon Shares	6,713	$20.11	$134,998.43	Disclosure SEC source: 0000884713-24-000045 · wk-form4_1715372366.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,445 F1 · shares: Common Shares were issued pursuant to the Primo Water Corporation 2018 Equity Incentive Plan in payment of the reporting person's annual director fee. The number of shares was calculated by dividing $135,000 (the cash amount of the annual director fee) by $20.11 (the closing price of the Common Shares on the New York Stock Exchange on May 8, 2024). Read SEC document
April 24, 2024 Filed Apr 26, 2024 21:13 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	539	$0.00	$0.00	Disclosure SEC source: 0001225208-24-005286 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,276 Read SEC document
July 05, 2023 Filed Jul 6, 2023 20:02 UTC	Diversey Holdings, Ltd. DSEY · Entity 111551	Disposition to issuerOrdinary Shares, $0.0001 par value	634,350	$8.40	$5,328,540.00	Disclosure SEC source: 0001104659-23-078710 · tm2320296-4_4seq1.xml · nonDerivative · entry 2 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to and in connection with the transactions contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 8, 2023, by and among the Issuer, Olympus Water Holdings IV, L.P. ("Parent"), acting by its general partner, Olympus Water Holdings Limited and Diamond Merger Limited, each of the Issuer's ordinary shares, par value $0.0001 per share (each, an "Ordinary Share"), owned by the Reporting Person were cancelled and exchanged into the right to receive $8.40 in cash (the "Merger Consideration"). F3 · shares: The Ordinary Shares reported as disposed by the Reporting Person include 2,601 shares underlying restricted share units which, pursuant to the Merger Agreement, were vested and cancelled into the right to receive an amount in cash equal to the Merger Consideration, with payment subject to continued service with Parent and its affiliates, as applicable. Read SEC document
July 05, 2023 Filed Jul 6, 2023 20:02 UTC	Diversey Holdings, Ltd. DSEY · Entity 111551	Disposition to issuerOrdinary Shares, $0.0001 par value	121,210	$8.40	$1,018,164.00	Disclosure SEC source: 0001104659-23-078710 · tm2320296-4_4seq1.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Eric J. Foss Revocable Trust Agreement Disclosed balance after: 0 F1 · kind: Pursuant to and in connection with the transactions contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 8, 2023, by and among the Issuer, Olympus Water Holdings IV, L.P. ("Parent"), acting by its general partner, Olympus Water Holdings Limited and Diamond Merger Limited, each of the Issuer's ordinary shares, par value $0.0001 per share (each, an "Ordinary Share"), owned by the Reporting Person were cancelled and exchanged into the right to receive $8.40 in cash (the "Merger Consideration"). F2 · ownership.nature: The number of shares reported were indirectly held within the Eric J. Foss Revocable Trust Agreement u/a/d 10/4/07 of which the Reporting Person is trustee. Read SEC document
May 31, 2023 Filed Jun 2, 2023 16:18 UTC	Primo Water Corp /CN/ PRMW · Entity 86195	GrantCommon Shares	10,489	$12.87	$134,993.43	Disclosure SEC source: 0000884713-23-000041 · wf-form4_168573708859123.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,732 F1 · shares: Common Shares were issued pursuant to the Primo Water Corporation 2018 Equity Incentive Plan in payment of the reporting person's annual director fee. The number of shares was calculated by dividing $135,000 (the cash amount of the annual director fee) by $12.87 (the closing price of the Common Shares on the New York Stock Exchange on May 31, 2023). Read SEC document
April 26, 2023 Filed Apr 28, 2023 21:10 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	765	$0.00	$0.00	Disclosure SEC source: 0001225208-23-005163 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,737 Read SEC document
March 15, 2023 Filed Mar 17, 2023 16:10 UTC	Primo Water Corp /CN/ PRMW · Entity 86195	GrantCommon Shares	1,243	$14.57	$18,110.51	Disclosure SEC source: 0000884713-23-000023 · wf-form4_167908379381208.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,243 F1 · shares: Common Shares were issued in payment of the reporting person's annual director fee for services to be rendered to the Board of Directors from March 15, 2023, the reporting person's date of appointment, to May 3, 2023, the date of the 2023 Annual and Special Meeting of Shareowners. The number of shares was calculated by pro-rating $135,000 (the cash amount of the annual long-term equity incentive fee) for the period of service and dividing the resulting figure by $14.57 (the closing price of the Common Shares on the New York Stock Exchange on March 15, 2023). Read SEC document
May 13, 2022 Filed May 16, 2022 20:15 UTC	Diversey Holdings, Ltd. DSEY · Entity 111551	PurchaseOrdinary Share, $0.0001 par value	121,210	$8.67	$1,050,781.61	Disclosure SEC source: 0001104659-22-061334 · tm2215612-1_4seq1.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Eric J. Foss Revocable Trust Agreement Disclosed balance after: 121,210 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $8.26 to $8.95, inclusive. The reporting person undertakes to provide Diversey Holdings, Ltd. ("Diversey"), any security holder of Diversey or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. F2 · ownership.nature: The number of shares reported are indirectly held within the Eric J. Foss Revocable Trust Agreement u/a/d 10/4/07 of which the Reporting Person is trustee. Read SEC document
April 27, 2022 Filed Apr 29, 2022 22:10 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	757	$0.00	$0.00	Disclosure SEC source: 0001225208-22-006301 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,972 Read SEC document
March 29, 2022 Filed Mar 31, 2022 20:24 UTC	Diversey Holdings, Ltd. DSEY · Entity 111551	GrantOrdinary Share, $0.0001 par value	28,618	$0.00	$0.00	Disclosure SEC source: 0001104659-22-041065 · tm2210921-3_4seq1.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634,350 F1 · security: The reporting person received (i) 26,017 restricted share units ("RSUs") and (ii) 2,601 deferred RSUs (the "DRSUs"), in each case, under the Diversey Holdings, Ltd. 2021 Omnibus Incentive Plan. The RSUs vest in full on March 29, 2023, subject to the reporting person's continued service to the issuer through the vesting date. The DRSUs fully vested on the grant date. Read SEC document
February 28, 2022 Filed Mar 3, 2022 01:06 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	199	$0.00	$0.00	Disclosure SEC source: 0001225208-22-003932 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,215 Read SEC document
November 30, 2021 Filed Dec 2, 2021 23:36 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	247	$0.00	$0.00	Disclosure SEC source: 0001225208-21-014404 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,016 Read SEC document
August 31, 2021 Filed Sep 2, 2021 21:55 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	224	$0.00	$0.00	Disclosure SEC source: 0001225208-21-011979 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,769 Read SEC document
May 28, 2021 Filed Jun 2, 2021 21:12 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	183	$0.00	$0.00	Disclosure SEC source: 0001225208-21-008827 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,545 Read SEC document
March 29, 2021 Filed Apr 1, 2021 01:19 UTC	Diversey Holdings, Ltd. DSEY · Entity 111551	GrantOrdinary Shares, $0.0001 par value	8,333	$0.00	$0.00	Disclosure SEC source: 0001104659-21-045049 · tm2111451-1_4seq1.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 605,732 F1 · security: In connection with the issuer's initial public offering, the reporting person received 8,333 restricted share units ("RSUs") under the Diversey Holdings, Ltd. 2021 Omnibus Incentive Plan. The RSUs vest in full on March 29, 2022, subject to the reporting person remaining in continuous employment with the issuer on the vesting date. Read SEC document
February 26, 2021 Filed Mar 2, 2021 22:29 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	226	$0.00	$0.00	Disclosure SEC source: 0001225208-21-004290 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,362 Read SEC document
November 30, 2020 Filed Dec 2, 2020 22:33 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	227	$0.00	$0.00	Disclosure SEC source: 0001225208-20-014149 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,136 Read SEC document
August 31, 2020 Filed Sep 2, 2020 21:35 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	267	$0.00	$0.00	Disclosure SEC source: 0001225208-20-011217 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,909 Read SEC document
June 15, 2020 Filed Jun 16, 2020 21:02 UTC	Cigna Group CI · Entity 550	PurchaseCommon Stock, $.01 Par Value	5,460	$187.37	$1,023,017.81	Disclosure SEC source: 0001225208-20-009042 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,642 F1 · price: Represents the weighted average price of the shares purchased. The prices actually paid ranged from $186.83 to $187.62 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares purchased at each price within the range. Read SEC document
May 29, 2020 Filed Jun 2, 2020 21:06 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	240	$0.00	$0.00	Disclosure SEC source: 0001225208-20-008483 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,182 Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:06 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	259	$0.00	$0.00	Disclosure SEC source: 0001225208-20-004179 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,942 Read SEC document
December 03, 2019 Filed Dec 5, 2019 22:26 UTC	Cigna Group CI · Entity 550	PurchaseCommon Stock, $.01 Par Value	4,100	$195.04	$799,659.90	Disclosure SEC source: 0001225208-19-015303 · doc4.xml · nonDerivative · entry 2 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,683 F2 · price: Represents the weighted average price of the shares purchased. The prices actually paid ranged from $194.32 to $195.30 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares purchased at each price within the range. Read SEC document
December 03, 2019 Filed Dec 5, 2019 22:26 UTC	Cigna Group CI · Entity 550	PurchaseCommon Stock, $.01 Par Value	6,100	$195.66	$1,193,505.26	Disclosure SEC source: 0001225208-19-015303 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,583 F1 · price: Represents the weighted average price of the shares purchased. The prices actually paid ranged from $195.33 to $195.90 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares purchased at each price within the range. Read SEC document
November 29, 2019 Filed Dec 3, 2019 00:41 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	237	$0.00	$0.00	Disclosure SEC source: 0001225208-19-015087 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,483 Read SEC document
August 30, 2019 Filed Sep 4, 2019 21:34 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	308	$0.00	$0.00	Disclosure SEC source: 0001225208-19-012163 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,246 Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:13 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	320	$0.00	$0.00	Disclosure SEC source: 0001225208-19-008807 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,938 Read SEC document
May 30, 2019 Filed Jun 3, 2019 22:21 UTC	Aramark ARMK · Entity 3359	GrantCommon Stock	468.041	$0.00	$0.00	Disclosure SEC source: 0001584509-19-000133 · wf-form4_155960049428273.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680,411.584 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document
February 28, 2019 Filed Mar 4, 2019 23:38 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $.01 Par Value	272	$0.00	$0.00	Disclosure SEC source: 0001225208-19-004400 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,618 Read SEC document
February 28, 2019 Filed Mar 4, 2019 21:44 UTC	Aramark ARMK · Entity 3359	GrantCommon Stock	536.993	$0.00	$0.00	Disclosure SEC source: 0001584509-19-000071 · wf-form4_155173586093516.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,679,943.543 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document
December 20, 2018 Filed Dec 26, 2018 18:44 UTC	Cigna Holding Co CI · Entity 161580	Disposition to issuerCommon Stock, $.25 Par Value	14,346	$0.00	$0.00	Disclosure SEC source: 0001567619-18-008656 · doc1.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote) F2 · kind: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30. F1 · price: Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote) F2 · price: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30. Read SEC document
December 20, 2018 Filed Dec 27, 2018 00:20 UTC	Cigna Group CI · Entity 550	GrantCommon Stock, $0.01 Par Value	14,346	$0.00	$0.00	Disclosure SEC source: 0001567619-18-008710 · doc1.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,346 F1 · kind: Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. ("New Cigna"), was acquired pursuant to the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote) F2 · kind: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30. F1 · price: Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. ("New Cigna"), was acquired pursuant to the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote) F2 · price: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30. Read SEC document
December 12, 2018 Filed Dec 13, 2018 02:20 UTC	Aramark ARMK · Entity 3359	PurchaseCommon Stock	92,564	$32.46	$3,004,183.13	Disclosure SEC source: 0001584509-18-000272 · wf-form4_154466763423216.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,679,406.55 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $32.21 to $32.72, inclusive. The reporting person undertakes to provide to Aramark, any security holder of Aramark, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document
December 06, 2018 Filed Dec 10, 2018 22:01 UTC	Aramark ARMK · Entity 3359	GrantCommon Stock	430.903	$0.00	$0.00	Disclosure SEC source: 0001584509-18-000257 · wf-form4_154447927060937.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,586,842.55 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document
November 30, 2018 Filed Dec 4, 2018 18:28 UTC	Cigna Holding Co CI · Entity 161580	GrantCommon Stock, $.25 Par Value	201	$0.00	$0.00	Disclosure SEC source: 0001225208-18-016219 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,346 Read SEC document
November 20, 2018 Filed Nov 21, 2018 21:53 UTC	Aramark ARMK · Entity 3359	Tax withholdingCommon Stock	6,705	$35.83	$240,240.15	Disclosure SEC source: 0001584509-18-000234 · wf-form4_154283721735990.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,586,411.647 F1 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units. F1 · shares: Represents shares withheld to pay taxes applicable to vesting of restricted stock units. Read SEC document
November 19, 2018 Filed Nov 20, 2018 23:19 UTC	Aramark ARMK · Entity 3359	Tax withholdingCommon Stock	10,143	$36.89	$374,175.27	Disclosure SEC source: 0001584509-18-000218 · wf-form4_154275595188041.xml · nonDerivative · entry 4 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,593,116.647 F2 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units. F2 · shares: Represents shares withheld to pay taxes applicable to vesting of restricted stock units. Read SEC document
November 18, 2018 Filed Nov 20, 2018 23:19 UTC	Aramark ARMK · Entity 3359	Tax withholdingCommon Stock	6,352	$36.89	$234,325.28	Disclosure SEC source: 0001584509-18-000218 · wf-form4_154275595188041.xml · nonDerivative · entry 3 FOSS ERIC J · CIK 0001197007 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,603,259.647 F2 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units. F2 · shares: Represents shares withheld to pay taxes applicable to vesting of restricted stock units. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.